uploads/2018/01/analysts-3.png

Understanding Analysts’ Ratings on MetLife

By

Updated

Analysts’ view

Of the 17 analysts covering MetLife (MET) in January 2018, six have given the stock “strong buy” recommendations, seven have given it “hold” recommendations, one has given it a “sell” recommendation, and three have given it “buy” recommendations. These ratings are slightly different compared to the previous month.

Of the 16 analysts covering MET in December 2017, three gave it “buy” recommendations, six gave it “strong buy” recommendations, one gave it a “sell” recommendation, and six gave it “hold” recommendations. In November 2017, these ratings were the same.

Article continues below advertisement

Ratings on other players

MetLife’s competitor (XLF) CNO Financial Group (CNO) is being covered by eight analysts as of January 2018. One has recommended a “strong sell” on the stock, six have recommended “holds,” and another one has recommended a “strong buy.” No analysts have suggested “buy” or “sell” positions on the stock.

Reinsurance Group of America (RGA) is being tracked by nine analysts as of January 2018. One has recommended a “strong buy,” six have recommended “holds,” and one has recommended a “strong sell” on the stock. The remaining analyst has recommended a “buy” on the stock.

Allstate Corporation (ALL) is being tracked by 21 analysts as of January 2018. Seven have recommended “holds,” two have recommended “strong sells,” one has recommended a “sell,” four have recommended “strong buys,” and the remaining seven have recommended “buys” on the stock.

Of the 21 analysts covering ALL in December 2017, eight recommended “holds,” one suggested a “strong sell,” one recommended a “sell,” four recommended “strong buys,” and seven recommended “buys” on the stock.

Advertisement

More From Market Realist